Literature DB >> 11424997

"Targeting" schizophrenia in mice.

J A Gogos1, M Karayiorgou.   

Abstract

The greatest challenge of schizophrenia research remains the identification of the multiple, common, interacting, and moderately penetrant mutations that interfere with the highly complex function of human brain and result to this devastating disease. The inaccessibility of the human central nervous system to experimental manipulations and the paramount difficulties in identifying genes for schizophrenia has led researchers to generate mouse models for candidate genes using gene-targeting approaches. Although such mouse models have proven very useful in deciphering the causes of several diseases of the central nervous system (such as neurodegenerative diseases), their use in dissecting the biology of schizophrenia is still in its infancy. We argue that progress in this direction depends highly on progress in human genetic studies and requires careful and critical interpretation of the accumulating data.

Entities:  

Mesh:

Year:  2001        PMID: 11424997

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

Review 1.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

2.  Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia.

Authors:  Jussi Väisänen; Jouni Ihalainen; Heikki Tanila; Eero Castrén
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

3.  Transcription factor SP4 is a susceptibility gene for bipolar disorder.

Authors:  Xianjin Zhou; Wei Tang; Tiffany A Greenwood; Shengzhen Guo; Lin He; Mark A Geyer; John R Kelsoe
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.